Fortrea reports Q4 book-to-bill >1.2x; exits 40% of TSAs; review clears trial conduct

Fortrea Holdings Inc.

Book-to-bill ratio exceeded 1.2x for Q4 2023 and for first six months as an independent company.
Exited approximately 40% of Transition Services Agreements with former parent by end of 2023.
Hired a recognized AI industry expert to lead machine learning efforts.
Independent expert review found no deficit in Fortrea's conduct on two ACELYRIN clinical trials.
Select new business proposals and awards were affected by news surrounding the clinical trials.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.7

Fortrea Holdings Inc. reported financial results for the fourth quarter of 2023.

Period: the fourth quarter of 2023
Result: reported results

Exact text from the filing

Fortrea Holdings Inc. (the “Company”) announced that it delivered a book-to-bill ratio that exceeded 1.2x for the fourth quarter of 2023.

View on SEC.gov

59 earnings releases filed in the last 30 days. Browse all earnings releases →

Fortrea Holdings Inc. filing history →

Source: SEC EDGAR

accession 0001965040-24-000002

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.